264 related articles for article (PubMed ID: 32592689)
21. Targeting LIF/LIFR signaling in cancer.
Viswanadhapalli S; Dileep KV; Zhang KYJ; Nair HB; Vadlamudi RK
Genes Dis; 2022 Jul; 9(4):973-980. PubMed ID: 35685476
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
[TBL] [Abstract][Full Text] [Related]
23. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
Streitfeld WS; Dalton AC; Howley BV; Howe PH
Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
[TBL] [Abstract][Full Text] [Related]
24. SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.
Lang C; Dai Y; Wu Z; Yang Q; He S; Zhang X; Guo W; Lai Y; Du H; Wang H; Ren D; Peng X
Mol Oncol; 2020 Apr; 14(4):808-828. PubMed ID: 31925912
[TBL] [Abstract][Full Text] [Related]
25. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
Song X; Wang H; Wu J; Sun Y
Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
[No Abstract] [Full Text] [Related]
26. LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker.
Chen D; Sun Y; Wei Y; Zhang P; Rezaeian AH; Teruya-Feldstein J; Gupta S; Liang H; Lin HK; Hung MC; Ma L
Nat Med; 2012 Oct; 18(10):1511-7. PubMed ID: 23001183
[TBL] [Abstract][Full Text] [Related]
27. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer.
Liu S; Gandler HI; Tošić I; Ye DQ; Giaccone ZT; Frank DA
Mol Cancer Res; 2021 Aug; 19(8):1283-1295. PubMed ID: 33931487
[TBL] [Abstract][Full Text] [Related]
28. Evidence that IL-6-type cytokine signaling in cardiomyocytes is inhibited by oxidative stress: parthenolide targets JAK1 activation by generating ROS.
Kurdi M; Booz GW
J Cell Physiol; 2007 Aug; 212(2):424-31. PubMed ID: 17385713
[TBL] [Abstract][Full Text] [Related]
29. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4.
Lv S; Ji L; Chen B; Liu S; Lei C; Liu X; Qi X; Wang Y; Lai-Han Leung E; Wang H; Zhang L; Yu X; Liu Z; Wei Q; Lu L
Oncogene; 2018 Mar; 37(10):1354-1368. PubMed ID: 29269867
[TBL] [Abstract][Full Text] [Related]
30. Leukemia inhibitory factor promotes tumor growth and metastasis in human osteosarcoma via activating STAT3.
Liu B; Lu Y; Li J; Liu Y; Liu J; Wang W
APMIS; 2015 Oct; 123(10):837-46. PubMed ID: 26271643
[TBL] [Abstract][Full Text] [Related]
31. LacdiNAc (GalNAcβ1-4GlcNAc) contributes to self-renewal of mouse embryonic stem cells by regulating leukemia inhibitory factor/STAT3 signaling.
Sasaki N; Shinomi M; Hirano K; Ui-Tei K; Nishihara S
Stem Cells; 2011 Apr; 29(4):641-50. PubMed ID: 21305673
[TBL] [Abstract][Full Text] [Related]
32. The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Spencer N; Rodriguez Sanchez AL; Gopalam R; Subbarayalu P; Medina DM; Yang X; Ramirez P; Randolph L; Aller EJ; Santhamma B; Rao MK; Tekmal RR; Nair HB; Kost ER; Vadlamudi RK; Viswanadhapalli S
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139260
[TBL] [Abstract][Full Text] [Related]
33. Deficient leukemia inhibitory factor signaling in muscle precursor cells from patients with type 2 diabetes.
Broholm C; Brandt C; Schultz NS; Nielsen AR; Pedersen BK; Scheele C
Am J Physiol Endocrinol Metab; 2012 Jul; 303(2):E283-92. PubMed ID: 22649064
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma.
Wang D; Liu K; Yang Y; Wang T; Rao Q; Guo W; Zhang Z
Future Oncol; 2020 Jan; 16(3):4461-4473. PubMed ID: 31854204
[TBL] [Abstract][Full Text] [Related]
35. Highly expressed long non-coding RNA FEZF1-AS1 promotes cells proliferation and metastasis through Notch signaling in prostate cancer.
Zhu LF; Song LD; Xu Q; Zhan JF
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5122-5132. PubMed ID: 31298365
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
[TBL] [Abstract][Full Text] [Related]
37. Leukemia inhibitory factor enhances endometrial stromal cell decidualization in humans and mice.
Shuya LL; Menkhorst EM; Yap J; Li P; Lane N; Dimitriadis E
PLoS One; 2011; 6(9):e25288. PubMed ID: 21966484
[TBL] [Abstract][Full Text] [Related]
38. Expression of leukemia inhibitory factor in the rat retina following acute ocular hypertension.
Hu Q; Huang C; Wang Y; Wu R
Mol Med Rep; 2015 Nov; 12(5):6577-83. PubMed ID: 26352383
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the leukemia inhibitory factor receptor (LIFR) gene and Lifr deficiency cause urinary tract malformations.
Kosfeld A; Brand F; Weiss AC; Kreuzer M; Goerk M; Martens H; Schubert S; Schäfer AK; Riehmer V; Hennies I; Bräsen JH; Pape L; Amann K; Krogvold L; Bjerre A; Daniel C; Kispert A; Haffner D; Weber RG
Hum Mol Genet; 2017 May; 26(9):1716-1731. PubMed ID: 28334964
[TBL] [Abstract][Full Text] [Related]
40. Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction.
Yue X; Zhao Y; Zhang C; Li J; Liu Z; Liu J; Hu W
Oncotarget; 2016 Jan; 7(4):3777-90. PubMed ID: 26716902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]